Approved for Maintenance treatment of asthma in patients aged 6 years and older, Maintenance treatment of airflow obstruction in COPD. Combines budesonide (inhaled corticosteroid) and formoterol (long-acting beta-2 agonist). Budesonide suppresses airway inflammation while formoterol provides rapid-onset, sustained bronchodilation. Side effects, costs, interactions, manufacturer, and generic…
Loading full data from Know Your Drugs Institute…